FINWIRES · TerminalLIVE
FINWIRES

$RPRX

2 stories mentioning RPRX

Every FINWIRES story that references RPRX, newest first.

Insider Trading

Royalty Pharma Insider Sold Shares Worth $3,476,116, According to a Recent SEC Filing

Terrance P. Coyne, Executive Vice President & CFO, on May 26, 2026, sold 64,399 shares in Royalty Pharma (RPRX) for $3,476,116. Following the Form 4 filing with the SEC, Coyne has control over a total of 50,390 Class A ordinary shares of the company, with 1,500 shares held directly and 48,890 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1802768/000181487626000022/xslF345X05/wk-form4_1780001297.xml

$RPRX
Insider Trading

Royalty Pharma Insider Sold Shares Worth $1,731,840, According to a Recent SEC Filing

Terrance P. Coyne, Executive Vice President & CFO, on April 28, 2026, sold 34,791 shares in Royalty Pharma (RPRX) for $1,731,840. Following the Form 4 filing with the SEC, Coyne has control over a total of 90,526 Class A ordinary shares of the company, with 1,500 shares held directly and 89,026 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1802768/000181487626000018/xslF345X05/wk-form4_1777586044.xml

$RPRX